Measles News and Research

RSS

Measles is a highly contagious, serious disease caused by a virus. It remains a leading cause of death among young children globally, despite the availability of a safe and effective vaccine. An estimated 197 000 people died from measles in 2007, mostly children under the age of five.

Measles is caused by a virus in the paramyxovirus family. The measles virus normally grows in the cells that line the back of the throat and the lungs. It is a human disease not known to occur in animals.

Persistence of viral RNA following acute infection

Professor Diane Griffin from the Johns Hopkins Bloomberg School of Public Health, USA, has recently explained the persistence mechanism of viral RNA in the human body after clinical recovery from acute infection.

6 Jun 2022

What role do children play in household transmission of COVID-19?

A new study published in the International Journal of Infectious Diseases reviews the literature systematically. It performs a meta-analysis to assess the prevalence of pediatric COVID-19 in clusters of families, estimate the household secondary attack rate of children, and compare the transmissibility of SARS-CoV-2 in different age groups.

14 May 2022

Research highlight reports on the observed differences in transmissibility and pathogenicity of Omicron vs. earlier variants of SARS-CoV-2

A new paper published in Signal Transduction and Targeted Therapy reports the observed differences in transmissibility and pathogenicity of Omicron vs. earlier variants of SARS-CoV-2.

10 May 2022

World Immunization Week 2022: Gavi, The Vaccine Alliance on the equitable and sustainable use of vaccines

As part of World Immunization Week 2022, News Medical speaks to Thabani Maphosa, the Managing Director of Country Programmes at Gavi, The Vaccine Alliance, about their work to increase equitable and sustainable use of vaccines by maximizing financial investments, bringing the best partners to the table and driving innovation.

27 Apr 2022

Eradicating Polio; What's it going to take?

In this interview, we speak to Judith Diment from Rotary’s International PolioPlus Committee about the incredible work they are doing to help eradicate polio worldwide.

26 Apr 2022

The challenges of Omicron

A new review published in sums up the position of Omicron as a potential threat to human health, especially in the context of controlling this pandemic.

25 Apr 2022

Anti-vaccine ideology gains ground as lawmakers seek to erode rules for kids’ shots

Not long ago, Kansas showed strong bipartisan support for vaccines as a tool to support a robust public health system.

21 Apr 2022

Better ventilation can prevent covid spread. But are companies paying attention?

Americans are abandoning their masks. They're done with physical distancing. And, let's face it, some people are just never going to get vaccinated.

19 Apr 2022

Impact of COVID-19 pandemic on vaccination campaigns for diseases preventable by vaccine

Researchers assess the influence of the COVID-19 pandemic on vaccine-preventable disease initiatives.

18 Apr 2022

Risk of myopericarditis following COVID-19 vaccination is very low, confirms study

The overall risk of myopericarditis following COVID-19 vaccination is very low, affecting 18 people per million vaccine doses. A new study published in The Lancet Respiratory Medicine, confirms that this risk is comparable to or lower following COVID-19 vaccination than other non-COVID-19 vaccines.

13 Apr 2022

COVID-19 vaccines and reports of menstrual disorders

A new study estimates the potential relationship between COVID-19 vaccines and menstrual disorders.

11 Apr 2022

Furin inhibitors as potential therapies to combat SARS-CoV-2 and other diseases

Furin inhibitors as potential therapeutics for treating COVID-19 and other diseases, wherein furin is integral for their pathogenicity and progression.

29 Mar 2022

Investigating SARS-CoV-2 detection using Raman microscopy

Researchers investigated the specific intracellular signature of SARS-CoV-2 infection using Raman microscopy.

29 Mar 2022

Algae found to inhibit SARS-CoV-2 infection in vitro

A new study demonstrated that dry algal powders inhibit SARS-CoV-2 in vitro.

25 Mar 2022

Rubella antibodies vs. COVID-19

A new study describes a potential relationship between antibody titers against the rubella virus and the severity of COVID-19.

22 Mar 2022

The effect of SARS-CoV-2 on the expression of CD48 in the lungs and in the peripheral blood of COVID-19 patients

Researchers performed an in situ analysis to evaluate the correlation between CD48 expression and COVID-19.

22 Mar 2022

SARS-CoV-2 in diabetes pathogenesis

Researchers reviewed the causes of diabetes mellitus, focusing on respiratory viruses, including influenza virus and SARS-CoV-2.

15 Mar 2022

Canadian scientist discusses about how society could better prepare for future pandemics

Aled Edwards is of two minds about medicine's response to COVID-19. On one hand, he notes, we had life-saving vaccines and therapies less than a year after the discovery of SARS-CoV-2. On the other, more than six million, and possibly as many as 18 million people have died, and global access to advances that can prevent and treat severe disease remains highly inequitable.

11 Mar 2022

Over a third vaccinated-but-unboosted adults have reservations about vaccinating children

While the vast majority of U.S. adults who are fully vaccinated and boosted against Covid-19 would be likely to recommend vaccinating a 5- to 11-year-old, over a third of fully vaccinated adults who have not had a booster shot have reservations about Covid-19 vaccination for a child that age, according to survey data analysis by the Annenberg Public Policy Center of the University of Pennsylvania.

3 Mar 2022

Why pregnant people were left behind while vaccines moved at ‘warp speed’ to help the masses

Kia Slade was seven months pregnant, unvaccinated, and fighting for breath, her oxygen levels plummeting, when her son came into the world last May.

24 Feb 2022